Genotype-guided antiplatelet treatment benefit patients with acute coronary syndrome
2019.06.24
Personalized medicine with antiplatelet treatment could decrease the risks of high on-treatment platelet reactivity (HTPR), all-cause mortality, myocardial infarction (MI) and stent thrombosis (ST)...